-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Amrize, Raises Price Target to $58

Benzinga·10/30/2025 14:58:41
Listen to the news
Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Overweight and raises the price target from $57 to $58.